Sirio Pharma Co., Ltd. (SHE:300791)
China · Delayed Price · Currency is CNY 17.59
+0.21 (1.21%)
Sep 14, 2026, 1:44 PM CST
Sirio Pharma Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 4,273 | 4,263 | 4,211 | 3,582 | 2,507 | 2,369 |
Revenue Growth | 0.26% | 1.23% | 17.56% | 42.87% | 5.84% | 14.62% |
Gross Profit Gross Profit Growth | 1,247 | 1,220 | 1,320 | 1,085 | 770.42 | 764.94 |
Operating Income Operating Income Growth | 248.23 | 209.97 | 396.78 | 376.33 | 242.59 | 281.11 |
Net Income Net Income Growth | 128.34 | 136.53 | 325.06 | 281.04 | 212.29 | 231.83 |
Earnings Per Share EPS Growth | 0.42 | 0.45 | 1.07 | 0.92 | 0.69 | 0.72 |
EPS Growth | -61.23% | -58.26% | 16.08% | 33.48% | -4.15% | -14.21% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
China China Growth | 1,715 | 1,661 | 1,851 | 1,491 | 1,458 |
Americas Americas Growth | 1,551 | 1,666 | 1,044 | 540.9 | 398.08 |
Europe Europe Growth | 755.3 | 604.48 | 529.11 | 395.52 | 435.36 |
Other Areas Other Areas Growth | 241.7 | 279.95 | 157.83 | 79.48 | 77.34 |
Total Total Growth | 4,263 | 4,211 | 3,582 | 2,507 | 2,369 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 782.42 | 698.34 | 776.4 | 755.14 | 1,690 | 1,246 |
Total Debt Total Debt Growth | 1,848 | 1,684 | 1,607 | 1,369 | 936.9 | 874.26 |
Net Cash (Debt) Net Cash Growth | -1,066 | -985.26 | -830.1 | -614.1 | 753.08 | 372.05 |
Net Cash Growth | - | - | - | - | 102.42% | -43.24% |
Net Cash Per Share Net Cash Per Share Growth | -3.52 | -3.22 | -2.73 | -2.02 | 2.45 | 1.16 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 603.48 | 570.18 | 566.97 | 386.08 | 444.86 | 341.38 |
Capital Expenditures CapEx Growth | -447.89 | -441.26 | -412.13 | -451.7 | -293.69 | -524.68 |
Free Cash Flow Free Cash Flow Growth | 155.59 | 128.92 | 154.84 | -65.62 | 151.17 | -183.31 |
Free Cash Flow Growth | -15.48% | -16.74% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 29.18% | 28.62% | 31.34% | 30.28% | 30.73% | 32.29% |
Operating Margin | 5.81% | 4.92% | 9.42% | 10.51% | 9.68% | 11.87% |
Pretax Margin | 0.27% | -0.14% | 7.52% | 7.63% | 10.03% | 11.86% |
Profit Margin | 3.00% | 3.20% | 7.72% | 7.85% | 8.47% | 9.79% |
FCF Margin | 3.64% | 3.02% | 3.68% | -1.83% | 6.03% | -7.74% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.130 | 0.130 | 0.500 | 0.651 | 0.207 | 0.237 |
Dividend Per Share Growth | -80.00% | -74.00% | -23.18% | 214.29% | -12.50% | 0% |
Dividend Yield | 0.72% | 0.51% | 2.54% | 3.37% | 1.02% | 1.05% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 41.04 | 57.95 | 18.97 | 22.39 | 31.26 | 32.41 |
Forward PE | 15.25 | 18.70 | 15.13 | 19.62 | 25.53 | 23.76 |
P/FCF Ratio | 34.30 | 61.37 | 39.83 | - | 43.90 | - |
PS Ratio | 1.25 | 1.86 | 1.46 | 1.76 | 2.65 | 3.17 |